Table 2 Demographic, clinical and laboratory data among AKI and non-AKI groups
Total | Non-AKI | AKI | p | |
|---|---|---|---|---|
Patients, % | 258 | 119 (46.1) | 139 (53.9) | |
Age, years (median, IQR) | 59 (52;65) | 59 (52;66) | 60 (53;65) | 0.630 |
Gender, male / female (%) | 185 (71.7) / 73 (28.3) | 83 (69.7) / 36 (30.3) | 102 (73.4) / 37 (26.6) | 0.580 |
Etiology, n (%) | ||||
Alcohol | 125 (48.4) | 55 (46.2) | 70 (50.4) | 0.534 |
Viral | 100 (38.8) | 41 (34.5) | 59 (42.4) | 0.202 |
Non-viral and Non-alcohol | 54 (20.9) | 30 (25.2) | 24 (17.3) | 0.127 |
Days of hospitalization (median, IQR) | 7 (3;13) | |||
ICU admission (%) | 78 (30.2) | 19 (16) | 59 (42.4) | < 0.001 |
admission MELD score (median, IQR) | 18 (14;23) | 16 (11;19) | 19 (16;25) | < 0.001 |
admission APACHE II (median, IQR) | 16 (12;22) | 14 (11;18) | 19 (14;23) | < 0.001 |
admission MAP (mmHg), (median, IQR) | 89 (75;100) | 89 (76;100) | 87 (74;100) | 0.679 |
Comorbidities, n (%) | ||||
Hypertension | 114 (44.2) | 51 (42.9) | 63 (45.3) | 0.708 |
Diabetes | 82 (31.8) | 36 (30.3) | 46 (33.1) | 0.688 |
Smoking (present or past) | 69 (26.7) | 30 (25.2) | 39 (28.1) | 0.673 |
Cancer | 57 (22.1) | 26 (21.8) | 31 (22.3) | 1 |
Hepatocarcinoma | 41 (70.7) | 19 (70.4) | 22 (71) | 1 |
Non-hepatocarcinoma | 17 (29.3) | 8 (29.6) | 9 (29) | |
Heart failure | 26 (10.1) | 11 (9.2) | 15 (10.8) | 0.836 |
Cause of hospitalization, n (%) | ||||
Infection | 138 (53.5) | 52 (37.7) | 86 (62.3) | 0.004 |
Non-infection | 120 (46.5) | 67 (55.8) | 53 (44.2) | |
Baseline eGFR (ml/min/1.73m2) (median, IQR) | 57 (35;80) | 66 (35;89) | 56 (35;73) | 0.073 |
Laboratory | ||||
Hemoglobin, g/dL (mean, SD) | 11.2 (2.75) | 11.3 (2.72) | 11.1 (2.78) | 0.493 |
Albumin, g/dL (mean, SD) | 2.9 (0.6) | 2.9 (0.6) | 2.8 (0.6) | 0.070 |
Leucocytes, 1000/uL (median, IQR) | 8.8 (5.7;12.4) | 7.7 (5.2;11) | 10 (6.7;13.5) | 0.001 |
Platelets, 1000/uL (median, IQR) | 126 (80;186) | 108.5 (70.5;174.5) | 137 (88;192) | 0.036 |
INR (median, IQR) | 1.4 (1.2;1.6) | 1.4 (1.2;1.6) | 1.5 (1.3;1.7) | 0.009 |
Total Bilirrubin, mg/dL (median, IQR) | 2.2 (1.0;4.7) | 2 (0.8;4) | 2 (1;4.6) | 0.370 |
Baseline Creatinine, mg/dL (median, IQR) | 1.04 (0.80; 1.58) | 0.96 (0.70;1.56) | 1.05 (0.85;1.59) | 0.081 |
Admission Creatinine, mg/dL (median,IQR) | 1.40 (0.85; 2.34) | 0.98 (0.72;1.60) | 1.80 (1.13;2.77) | < 0.001 |
Peak Creatinine, mg/dL (median, IQR) | 1.9 (1.01; 2.98) | 0.99 (0.75;1.56) | 2.55 (1.93;3.85) | < 0.001 |
Sodium (median, IQR) | 136 (132; 139) | 137 (133;140) | 136 (132;139) | 0.078 |
Urea, mg/dL (median, IQR) | 61 (34;99) | 39 (27;70) | 78 (46;108) | < 0.001 |